Science Explorer Back to mapMap
Discussion
Researcher · Eli Lilly (United States) · United States

Axel Haupt

Axel Haupt publishes mostly in Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology, on topics such as Diabetes Treatment and Management, Diabetes Management and Research and Metabolism, Diabetes, and Cancer.

ORCID 0000-0003-4502-0470 OpenAlex
World rank
#115,011
of 7,710,434 ranked researchers
Rank in United States
#43,845
of 1,627,098
Works
188
Citations
11k
Citations per work
60.8
h-index
48
i10-index 84Top 3.6% in Endocrinology, Diabetes and Metabolism
Axel Haupt

What does Axel Haupt research?

Axel Haupt's work is mostly in Medicine (55%), Biochemistry, Genetics and Molecular Biology (14%).

Health Sciences: 104 works · 55.2% of their workMedicine: 104 works · 55.2% of their workEndocrinology, Diabetes and Metabolism: 62 works · 33.1% of their workSurgery: 21 works · 11.0% of their workEpidemiology: 11 works · 6.1% of their workPharmacology: 9 works · 5.0% of their workEverything else: 57 works · 30.5% of their workLife Sciences: 27 works · 14.3% of their workBiochemistry, Genetics and Molecular Biology: 27 works · 14.3% of their workMolecular Biology: 17 works · 9.0% of their workGenetics: 10 works · 5.3% of their workTHEIR WORKAxel Haupt188works
Life Sciences14%Health Sciences55%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine10455.2%
  2. Everything else5730.5%
    1. Biochemistry, Genetics and Molecular Biology2714.3%
  1. 1Endocrinology, Diabetes and Metabolism33% of their works
  2. 2Surgery11% of their works
  3. 3Molecular Biology9% of their works
  4. 4Epidemiology6% of their works
  5. 5Genetics5% of their works
  6. 6Pharmacology5% of their works

Research topics

Which keywords describe Axel Haupt's research?

The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Cardiovascular Outcomes, Type 2 Diabetes, Metabolic Syndrome, Cardiovascular Disease, Diabetes and Obesity.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 24 words, with their numbers
  1. Glycemic Control1012 topics
  2. Insulin Therapy1012 topics
  3. Cardiovascular Outcomes721 topic
  4. Type 2 Diabetes721 topic
  5. Metabolic Syndrome483 topics
  6. Cardiovascular Disease462 topics
  7. Diabetes462 topics
  8. Obesity392 topics
  9. Weight Loss372 topics
  10. Insulin Resistance332 topics
  11. Continuous Glucose Monitoring291 topic
  12. Hypoglycemia291 topic
  13. AMP-Activated Protein Kinase261 topic
  14. Metformin261 topic
  15. Anti-Obesity Drugs221 topic
  16. Pancreatic Islets221 topic
  17. Pharmacotherapy221 topic
  18. ß-Cell Dysfunction221 topic
  19. Atherosclerosis171 topic
  20. Glucose Metabolism171 topic
  21. NAFLD161 topic
  22. NASH161 topic
  23. Ketogenic Diet151 topic
  24. Low-Carbohydrate Diet151 topic

Where does Axel Haupt work?

Axel Haupt's main affiliation in the publication record is Eli Lilly (United States), United States.

How many publications and citations does Axel Haupt have?

OpenAlex counts 188 works and 11,433 citations for Axel Haupt, an h-index of 48, ranking #115,011 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Axel Haupt

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Axel Haupt. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.